Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Excessive patient loads were the greatest cause of moral distress among health personnel during the pandemic

Written by | 27 May 2024

Moral distress is the psychological harm that arises when people are forced to witness or perform actions that clash with their moral values. It is a problem that… read more.

How long COVID survivors are revolutionizing health care

Written by | 29 Mar 2024

To the world’s public health authorities, Covid-19 would be either a deadly disease for some or a simple respiratory illness for most, its symptoms clearing up in just… read more.

Positive topline results from phase II study evaluating Ampligen (rinatatolimod) for the treatment of post-COVID conditions – AIM ImmunoTech Inc

Written by | 18 Feb 2024

AIM ImmunoTech Inc. announced positive topline results from the Company’s Phase II study evaluating the efficacy and safety of Ampligen as a potential therapeutic for people with the… read more.

Ten per cent treatment boost needed to shift NHS Covid backlog

Written by | 21 Jan 2024

The NHS must treat at least 10 per cent more non-emergency hospital cases a month if it is to successfully start reducing the hefty backlog caused by the… read more.

France recorded ‘post-COVID’ surge in meningococcal disease

Written by | 13 Jan 2024

An unprecedented resurgence in invasive meningococcal disease followed the lifting of pandemic restrictions in France, according to a paper published in the Journal of Infection and Public Health… read more.

‘Long flu’ has emerged as a consequence similar to long COVID

Written by | 21 Dec 2023

Since the COVID-19 pandemic began, extensive research has emerged detailing the virus’s ability to attack multiple organ systems, potentially resulting in a set of enduring and often disabling… read more.

Final results for VV116 (mindeudesivir hydrobromide) shows efficacy in COVID 19 trial – Junishi Biosciences

Written by | 2 Dec 2023

Junshi Biosciences has revealed the final results for its Covid-19 pill VV 116 (mindeudesivir hydrobromide), indicating its efficacy. The data, which was published in The Lancet Infectious Diseases… read more.

Virologic rebound in Covid-19 is higher than expected among Paxlovid patients

Written by | 16 Nov 2023

Researchers from a study of patients treated for acute COVID-19 report that virologic rebound takes place in about 20.8 percent of subjects treated with nirmatrelvir-ritonavir (N-R, Paxlovid) versus… read more.

Survey finds many Americans are letting their guard down during respiratory illness season

Written by | 12 Nov 2023

Despite the Centers for Disease Control and Prevention warning this year will be potentially dangerous for respiratory illnesses, a third of Americans are not concerned about the threat,… read more.

Financial insecurity common among frontline healthcare workers during COVID-19

Written by | 30 Oct 2023

Many frontline health care workers in the United States experienced food insecurity and other significant financial challenges during the COVID-19 pandemic, according to a recent study led by… read more.

Covid conspiracies: social media fatigue linked to misinformation

Written by | 21 Oct 2023

The spread of false information and conspiracy theories accelerated during the peak of the COVID-19 pandemic. Inadvertently inaccurate, and some deliberately misleading, ideas were widely shared on social… read more.

New research finds greater continuity of psychotherapy after shift to telehealth

Written by | 14 Oct 2023

The rapid transition to virtual care that occurred with the onset of the COVID-19 pandemic resulted in better continuity of psychotherapy visits compared to prior to the pandemic… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.